Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy AVEO Pharmaceuticals stock

Learn how to easily invest in AVEO Pharmaceuticals stock.

AVEO Pharmaceuticals Inc is a biotechnology business based in the US. AVEO Pharmaceuticals shares (AVEO) are listed on the NASDAQ and all prices are listed in US Dollars. AVEO Pharmaceuticals employs 114 staff and has a trailing 12-month revenue of around $79 million.

How to buy shares in AVEO Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AVEO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

AVEO Pharmaceuticals stock price (NASDAQ: AVEO)

Use our graph to track the performance of AVEO stocks over time.

AVEO Pharmaceuticals shares at a glance

Information last updated 2022-09-23.
Latest market close$8.14
52-week range$3.06 - $9.37
50-day moving average $7.75
200-day moving average $5.46
Wall St. target price$15.60
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.20

Buy AVEO Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy AVEO Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AVEO Pharmaceuticals price performance over time

Historical closes compared with the close of $8.14 from 2022-09-29

1 week (2022-09-23) 5.03%
1 month (2022-09-01) -2.63%
3 months (2022-07-01) 21.31%
6 months (2022-03-31) 45.62%
1 year (2021-10-01) 29.82%
2 years (2020-10-01) 37.27%
3 years (2019-10-01) 880.49%
5 years (2017-09-29) 123.01%

AVEO Pharmaceuticals financials

Revenue TTM $79 million
Gross profit TTM $11.3 million
Return on assets TTM -18.68%
Return on equity TTM -79.61%
Profit margin -45.72%
Book value $0.88
Market capitalisation $281.4 million

TTM: trailing 12 months

AVEO Pharmaceuticals share dividends

We're not expecting AVEO Pharmaceuticals to pay a dividend over the next 12 months.

Have AVEO Pharmaceuticals's shares ever split?

AVEO Pharmaceuticals's shares were split on a 1:10 basis on 19 February 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your AVEO Pharmaceuticals shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for AVEO Pharmaceuticals shares which in turn could have impacted AVEO Pharmaceuticals's share price.

AVEO Pharmaceuticals share price volatility

Over the last 12 months, AVEO Pharmaceuticals's shares have ranged in value from as little as $3.06 up to $9.37. A popular way to gauge a stock's volatility is its "beta".

AVEO.US volatility(beta: 0.75)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AVEO Pharmaceuticals's is 0.7535. This would suggest that AVEO Pharmaceuticals's shares are less volatile than average (for this exchange).

AVEO Pharmaceuticals overview

AVEO Pharmaceuticals, Inc. , an oncology-focused biopharmaceutical company, focuses on developing and commercializing medicines for patients with cancer. It markets FOTIVDA, an oral, next-generation vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC). The company is also developing tivozanib for the treatment of RCC, hepatocellular carcinoma, ovarian cancer, immunologically cold tumors, and cholangiocarcinoma. In addition, it is developing Ficlatuzumab, a potent humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets hepatocyte growth factor that is in a Phase II clinical trial for the treatment of head and neck squamous cell carcinoma, pancreatic cancer, and acute myeloid leukemia; AV-380, a potent humanized IgG1 inhibitory monoclonal antibody for the treatment or prevention of cachexia; AV-203, a potent humanized IgG1 monoclonal antibody that targets ErbB3; and AV-353 that targets the Notch 3 pathway. The company has collaborations and license agreements with AstraZeneca PLC; EUSA Pharma (UK) Limited; Biodesix, Inc. ; CANbridge Life Sciences, Ltd.

Frequently asked questions

What percentage of AVEO Pharmaceuticals is owned by insiders or institutions?
Currently 0.188% of AVEO Pharmaceuticals shares are held by insiders and 45.374% by institutions.
How many people work for AVEO Pharmaceuticals?
Latest data suggests 114 work at AVEO Pharmaceuticals.
When does the fiscal year end for AVEO Pharmaceuticals?
AVEO Pharmaceuticals's fiscal year ends in December.
Where is AVEO Pharmaceuticals based?
AVEO Pharmaceuticals's address is: 30 Winter Street, Boston, MA, United States, 02108
What is AVEO Pharmaceuticals's ISIN number?
AVEO Pharmaceuticals's international securities identification number is: US0535883070
What is AVEO Pharmaceuticals's CUSIP number?
AVEO Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 053588109

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site